Neuroethics

, Volume 10, Issue 2, pp 243–254 | Cite as

Why Enhancing Autonomy Is Not a Question of Improving Single Aspects of Reasoning Abilities through Neuroenhancement

Original Article

Abstract

In a recent paper, Schaefer et al. proposed to enhance autonomy via improving reasoning abilities through (genetic) cognitive enhancement [1]. While initially their idea additionally seems to elegantly avoid objections against genetic enhancements based on the value of autonomy, we want to draw attention to several problems their approach poses. First, we will show that it is not at all clear that safe and meaningful methods to genetically or pharmaceutically enhance cognition will be feasible any time soon. Second, we want to provide a deeper discussion of the role of cognition and reasoning abilities in philosophical concepts of autonomy, as discussed in the mentioned paper. In doing so, we wish to demonstrate that using reasoning abilities as the common denominator in different accounts of autonomy in the context of enhancement does not do justice to the highly complex interrelations between cognition, reasoning abilities and autonomy. Neither should this way of arguing be accepted as a basis to call for practical outcomes, such as funding research into e. g. genetic cognitive enhancements, if the examined concepts of autonomy are taken seriously.

Keywords

Autonomy Genetic enhancement Neuroenhancement Reasoning abilities Cognition 

References

  1. 1.
    Schaefer, G.O., G. Kahane, and J. Savulescu. 2014. Autonomy and enhancement. Neuroethics 7(2): 123–136.CrossRefGoogle Scholar
  2. 2.
    Habermas, J. 2003. The future of human nature. Cambridge: PolityPress.Google Scholar
  3. 3.
    Davis, D.S. 2009. The parental investment factor and the Child’s right to an open future. Hastings Center Report 39(2): 24–27.CrossRefGoogle Scholar
  4. 4.
    Davis, D.S. 1997. Genetic dilemmas and the Child’s right to an open future. Hastings Center Report 27(2): 7–15.CrossRefGoogle Scholar
  5. 5.
    Savulescu, J., R. ter Meulen, and G. Kahane. 2011. Enhancing human capacities. Chichester: Blackwell Publishing Ltd..CrossRefGoogle Scholar
  6. 6.
    Bostrom, N., and A. Sandberg. 2009. Cognitive enhancement: methods, ethics, regulatory challenges. Science & Engineering Ethics 15(3): 311–341.CrossRefGoogle Scholar
  7. 7.
    Housden, C.R., S. Morein-Zamir, and B.J. Sahakian. 2011. Cognitivie enhancing drugs: neuroscience and society. In Enhancing human capacities, ed. G. Kahane, J. Savulescu, and R. Ter Meulen, 113–126. Chichester: Wiley.Google Scholar
  8. 8.
    Persson, I., and J. Savulescu. 2008. The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity. Journal of Applied Philosophy 25(3): 162–177.CrossRefGoogle Scholar
  9. 9.
    Zohny, H. 2015. The myth of cognitive enhancement drugs. Neuroethics 8(3): 257–269.CrossRefGoogle Scholar
  10. 10.
    Singh, I., I. Bard, and J. Jackson. 2014. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PloS One 9(10): e105969.CrossRefGoogle Scholar
  11. 11.
    Quednow, B.B. 2010. Ethics of neuroenhancement. A phantom debate. BioSocieties 5(1): 153–156.CrossRefGoogle Scholar
  12. 12.
    de Jongh, R., I. Bolt, M. Schermer, and B. Olivier. 2008. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32(4): 760–776.CrossRefGoogle Scholar
  13. 13.
    Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2011. Deflating the neuroenhancement bubble. American Journal of Bioethics Neuroscience 2(4): 38–43.Google Scholar
  14. 14.
    Hall, W.D., and J.C. Lucke. 2010. The enhancement use of Neuropharmaceuticals: more Scepticism and caution needed. Addiction 105(12): 2041–2043.CrossRefGoogle Scholar
  15. 15.
    Lucke, J.C., S. Bell, B. Partridge, and W.D. Hall. 2010. Weak evidence for large claims contribute to the phantom debate. BioSocieties 5(4): 482–483.CrossRefGoogle Scholar
  16. 16.
    Nadler, R.C., and P.B. Reiner. 2010. A call for data to inform discussion on cognitive enhancement. BioSocieties 5(4): 481–482.CrossRefGoogle Scholar
  17. 17.
    McCabe, S.E., C.J. Teter, C.J. Boyd, J.R. Knight, and H. Wechsler. 2005. Nonmedical use of prescription opioids among US College students: prevalence and correlates from a National Survey. Addictive Behaviors 30(4): 789–805.CrossRefGoogle Scholar
  18. 18.
    Maher, B. 2008. Poll results: look Who’s doping. Nature 452: 674–675.CrossRefGoogle Scholar
  19. 19.
    Babcock, Q., and T. Byrne. 2000. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 49(3): 143–145.CrossRefGoogle Scholar
  20. 20.
    Franke, A.G., C. Bonertz, M. Christmann, M. Huss, A. Fellgiebel, E. Hildt, and K. Lieb. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(2): 60–66.CrossRefGoogle Scholar
  21. 21.
    Wiegel, C., S. Sattler, A.S. Göritz, and M. Diewald. 2016. Work-related stress and cognitive enhancement among university teachers. Anxiety, Stress, and Coping 29(1): 100–117.CrossRefGoogle Scholar
  22. 22.
    Bouchard, T.J., and M. McGue. 1981. Familial studies of intelligence: a review. Science 212(4498): 1055–1059.CrossRefGoogle Scholar
  23. 23.
    Plucker, J.A., and A.L. Shelton. 2015. General intelligence (g): overview of a complex construct and its implications for genetics research. Hastings Center Report 45(S1): S21–S24.CrossRefGoogle Scholar
  24. 24.
    Turkheimer, E. 2015. Genetic prediction. Hastings Center Report 45(S1): S32–S38.CrossRefGoogle Scholar
  25. 25.
    Wray, N.R., J. Yang, B.J. Hayes, A.L. Price, M.E. Goddard, and P.M. Visscher. 2013. Pitfalls of predicting complex traits from SNPs. Nature Reviews Genetics 14(7): 507–515.CrossRefGoogle Scholar
  26. 26.
    Tabery, J. 2015. Why is studying the genetics of intelligence so controversial? Hastings Center Report 45(S1): S9–S14.CrossRefGoogle Scholar
  27. 27.
    McGue, M., and I.I. Gottesman. 2015. Classical and molecular genetic research on general cognitive ability. Hastings Center Report 45(S1): S25–S31.CrossRefGoogle Scholar
  28. 28.
    Turkheimer, E. 2016. Weak genetic explanation 20 Years later: reply to Plomin et al. Perspectives on Psychological Science 11(1): 24–28.CrossRefGoogle Scholar
  29. 29.
    Chabris, C.F., J.J. Lee, D. Cesarini, D.J. Benjamin, and D.I. Laibson. 2015. The fourth law of behavior genetics. Current Directions in Psychological Science 24(4): 304–312.CrossRefGoogle Scholar
  30. 30.
    Davies, G., et al. 2015. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N = 53949). Molecular Psychiatry 20(2): 183–192.CrossRefGoogle Scholar
  31. 31.
    Burdick, K.E., T. Lencz, B. Funke, C.T. Finn, P.R. Szeszko, J.M. Kane, R. Kucherlapati, and A.K. Malhotra. 2006. Genetic variation in DTNBP1 influences general cognitive ability. Human Molecular Genetics 15(10): 1563–1568.CrossRefGoogle Scholar
  32. 32.
    Deary, I.J., S.E. Harris, H.C. Fox, C. Hayward, A.F. Wright, J.M. Starr, and L.J. Whalley. 2005. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neuroscience Letters 378(1): 22–27.CrossRefGoogle Scholar
  33. 33.
    Harris, S.E., H. Fox, A.F. Wright, C. Hayward, J.M. Starr, L.J. Whalley, and I.J. Deary. 2006. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry 11(5): 505–513.CrossRefGoogle Scholar
  34. 34.
    Houlihan, L.M., S.E. Harris, M. Luciano, A.J. Gow, J.M. Starr, P.M. Visscher, and I.J. Deary. 2009. Replication study of candidate genes for cognitive abilities: the Lothian birth cohort 1936. Genes, Brain and Behavior 8(2): 238–247.CrossRefGoogle Scholar
  35. 35.
    Rosoff, P.M. 2012. The myth of genetic enhancement. Theoretical Medicine and Bioethics 33(3): 163–178.CrossRefGoogle Scholar
  36. 36.
    Sparrow, R. 2014. Better living through chemistry? A reply to Savulescu and Persson on ‘moral enhancement’. Journal of Applied Philosophy 31(1): 23–32.CrossRefGoogle Scholar
  37. 37.
    Feinberg, J. 1986. Harm to self. New York: Oxford University Press.Google Scholar
  38. 38.
    Friedrich, O., and J.H. Heinrichs. 2014. Autonomie als Rechtfertigungsgrund Psychiatrischer Therapien. Ethik in der Medizin 26(4): 317–330.CrossRefGoogle Scholar
  39. 39.
    Quante, M. 2011. In Defence of personal autonomy. Journal of Medical Ethics 37(10): 597–600.CrossRefGoogle Scholar
  40. 40.
    Beauchamp, T., and J. Childress. 2009. Principles of biomedical ethics. Oxford: Oxford University Press.Google Scholar
  41. 41.
    Stewart, C., C. Peisah, and B. Draper. 2011. A test for mental capacity to request assisted suicide. Journal of Medical Ethics 37(1): 34–39.CrossRefGoogle Scholar
  42. 42.
    Whalley, L.J., J.M. Starr, R. Athawes, D. Hunter, A. Pattie, and I.J. Deary. 2000. Childhood mental ability and dementia. Neurology 55(10): 1455–1459.CrossRefGoogle Scholar
  43. 43.
    Deary, I.J., M.C. Whiteman, J.M. Starr, L.J. Whalley, and H.C. Fox. 2004. The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. Journal of Personality and Social Psychology 86(1): 130–147.CrossRefGoogle Scholar
  44. 44.
    McGurn, B., I.J. Deary, and J.M. Starr. 2008. Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia. Neurology 71(14): 1051–1056.CrossRefGoogle Scholar
  45. 45.
    Szymanski, L., and B.H. King. 1999. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. Journal of the American Academy of Child & Adolescent Psychiatry 38(12): 5S–31S.CrossRefGoogle Scholar
  46. 46.
    Kaufman, L., M. Ayub, and J.B. Vincent. 2010. The genetic basis of non-syndromic intellectual disability: a review. Journal of Neurodevelopmental Disorders 2(4): 182–209.CrossRefGoogle Scholar
  47. 47.
    Khandaker, G.M., J.H. Barnett, I.R. White, and P.B. Jones. 2011. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132(2): 220–227.CrossRefGoogle Scholar
  48. 48.
    Koenen, K.C., T.E. Moffitt, A.L. Roberts, L.T. Martin, L. Kubzansky, H.L. Harrington, R. Poulton, and A. Caspi. 2009. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. American Journal of Psychiatry 166(1): 50–57.CrossRefGoogle Scholar
  49. 49.
    Levin, S.B. 2016. Upgrading discussions of cognitive enhancement. Neuroethics 9(1): 53–67.CrossRefGoogle Scholar
  50. 50.
    Elliott, C. 1998. The tyranny of happiness: ethics and cosmetic psychopharmacology. In Enhancing human traits: ethical and social implications, ed. E. Parens, 177–188. Washington D.C: Georgetown University Press.Google Scholar
  51. 51.
    Levy, N. 2011. Enhancing authenticity. Journal of Applied Philosophy 28(3): 308–318.CrossRefGoogle Scholar
  52. 52.
    DeGrazia, D. 2000. Prozac, enhancement, and self-creation. Hastings Center Report 30(2): 34–40.CrossRefGoogle Scholar
  53. 53.
    Wikler, D. 1979. Paternalism and the mildly retarded. Philosophy and Public Affairs 8(4): 377–392.Google Scholar
  54. 54.
    Frankfurt, H.G. 1971. Freedom of the will and the concept of a person. Journal of Philosophy 68(1): 5–20.CrossRefGoogle Scholar
  55. 55.
    Dworkin, G. 1988. The theory and practice of autonomy. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  56. 56.
    Young, R. 1989. Autonomy and the inner self. In The inner citadel: essays on individual autonomy, ed. J. Christman, 77–90. New York: Oxford University Press.Google Scholar
  57. 57.
    Richards, D.A.J. 1981. Rights and autonomy. Ethics 92(1): 3–20.CrossRefGoogle Scholar
  58. 58.
    Shedler, J. 2010. The efficacy of psychodynamic psychotherapy. The American Psychologist 65(2): 98–109.CrossRefGoogle Scholar
  59. 59.
    Mele, A. 2001. Autonomous Agents. New York: Oxford University Press.CrossRefGoogle Scholar
  60. 60.
    Heilinger, J.C., and K. Crone. 2014. Human freedom and enhancement. Medicine, Health Care and Philosophy 17(1): 13–21.CrossRefGoogle Scholar
  61. 61.
    Kant, I. 1997 [1785]. Grundlegung zur Metaphysik der Sitten [groundwork of the metaphysics of morals]. In Ak IV, ed. M. Gregor, 387–436. Cambridge: Cambridge University Press.Google Scholar
  62. 62.
    Oshana, M. 1998. Personal autonomy and society. Journal of Social Philosophy 29(1): 81–102.CrossRefGoogle Scholar
  63. 63.
    Christman, J. 1991. Autonomy and personal history. Canadian Journal of Philosophy 21(1): 1–24.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2017

Authors and Affiliations

  1. 1.Institute of Ethics, History and Theory of MedicineLudwig-Maximilians-University MunichMunichGermany

Personalised recommendations